UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells

Endocrine-related cancer, 2013-12, Vol.20 (6), p.797-808

2013

Volltextzugriff (PDF)

Impact of socioeconomic and medical factors on racial disparities in time to treatment initiation and survival in breast cancer patients

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18583-e18583

2022

Volltextzugriff (PDF)

Real‐world data on safety and efficacy of venetoclax‐based regimens in relapsed/refractory t(11;14) multiple myeloma

British journal of haematology, 2020-06, Vol.189 (6), p.1136-1140

2020

Volltextzugriff (PDF)

Abstract P5-14-13: Impact of race on time to treatment initiation and survival in breast cancer patients

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P5-P5-14-13

2022

Volltextzugriff (PDF)

Outcomes in AL Amyloidosis: A Single Institution Experience

Blood, 2020-11, Vol.136 (Supplement 1), p.32-32

2020

Volltextzugriff (PDF)

Sector retinitis pigmentosa: Report of ten cases and a review of the literature

Molecular vision, 2019, Vol.25, p.869-889

2019

Volltextzugriff (PDF)

Abstract A063: Critical factors influencing clinical trial enrollment and autologous stem cell transplantation in African-American patients with multiple myeloma: A retrospective, interview-based analysis

Cancer epidemiology, biomarkers & prevention, 2023-12, Vol.32 (12_Supplement), p.A063-A063

2023

Volltextzugriff (PDF)

Immunotherapy versus targeted therapy in the adjuvant setting for resected stage III melanoma: A single institution study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e21578-e21578

2022

Volltextzugriff (PDF)

Insights into Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: A 12-Year Experience of a Large Academic Center

Blood, 2023-11, Vol.142 (Supplement 1), p.3407-3407

2023

Volltextzugriff (PDF)

Outcomes of Venetoclax-Based Therapy in Patients with Daratumumab-Refractory t(11;14) Positive Light Chain Amyloidosis

Blood, 2023-11, Vol.142 (Supplement 1), p.2031-2031

2023

Volltextzugriff (PDF)

Outcomes of Salvage VDT-PACE-like Regimens in Relapsed-Refractory Multiple Myeloma: 10-Year Experience of a Large Academic Institution

Blood, 2023-11, Vol.142 (Supplement 1), p.4724-4724

2023

Volltextzugriff (PDF)

Abstract C115: Framework for a community-based multiple myeloma screening program

Cancer epidemiology, biomarkers & prevention, 2023-12, Vol.32 (12_Supplement), p.C115-C115

2023

Volltextzugriff (PDF)

Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory t[11;14] Multiple Myeloma

Blood, 2019-11, Vol.134 (Supplement_1), p.5566-5566

2019

Volltextzugriff (PDF)

P-103 Real World Data on Efficacy and Safety of Low-Dose Direct Oral Anticoagulants (DOACs) for Venous Thromboembolism (VTE) Prophylaxis in Newly Diagnosed Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S102-S102

2024

Volltextzugriff (PDF)

Episodic weakness and vacuolar myopathy in hypokalemic periodic paralysis

Journal of clinical neuroscience, 2015-11, Vol.22 (11), p.1846-1847

2015

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells

Impact of socioeconomic and medical factors on racial disparities in time to treatment initiation and survival in breast cancer patients

Real‐world data on safety and efficacy of venetoclax‐based regimens in relapsed/refractory t(11;14) multiple myeloma

Abstract P5-14-13: Impact of race on time to treatment initiation and survival in breast cancer patients

Outcomes in AL Amyloidosis: A Single Institution Experience

Sector retinitis pigmentosa: Report of ten cases and a review of the literature

Abstract A063: Critical factors influencing clinical trial enrollment and autologous stem cell transplantation in African-American patients with multiple myeloma: A retrospective, interview-based analysis

Immunotherapy versus targeted therapy in the adjuvant setting for resected stage III melanoma: A single institution study

Insights into Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: A 12-Year Experience of a Large Academic Center

Outcomes of Venetoclax-Based Therapy in Patients with Daratumumab-Refractory t(11;14) Positive Light Chain Amyloidosis

Outcomes of Salvage VDT-PACE-like Regimens in Relapsed-Refractory Multiple Myeloma: 10-Year Experience of a Large Academic Institution

Abstract C115: Framework for a community-based multiple myeloma screening program

Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory t[11;14] Multiple Myeloma

P-103 Real World Data on Efficacy and Safety of Low-Dose Direct Oral Anticoagulants (DOACs) for Venous Thromboembolism (VTE) Prophylaxis in Newly Diagnosed Multiple Myeloma

Episodic weakness and vacuolar myopathy in hypokalemic periodic paralysis

Suchergebnisse filtern